CNBC Stock Blog
- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
- Global Growth Good for Portfolio: Stock Picker
- Expect Tech Sector to Rise in Q4: Strategist
- Expect a 5-10% Market Pullback: Stock Picker
- 3 Stock Picks for This Volatile Environment: Portfolio Manager
- 3 Financial Stocks May Lead Final Rally: Market Researcher
- Gold's 'Money' Value is $4,000 to $11,000: Market Strategist
- Commercial Real Estate Bottom Near: Market Pro
MOST SHARED
- Wall Street Finds Profits by Reducing Mortgages
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- What if a Recovery Is All in Your Head?
- Kraft Weighs Higher Cadbury Bid as Rivals Circle
- Gold Prices to See Correction in 2010: Analyst
- Oil Prices to be Range-Bound This Week: CNBC Survey
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- U.S. Stocks Slip, Dollar Rises
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
- Smallest US Businesses Borrowing Again: PayNet
- Wave of Debt Payments Facing US Government
- US Job Losses to Bottom out Next Quarter: NABE
- Little Sign of Inflation on the Horizon: IMF
- Kraft Weighs Higher Cadbury Bid as Rivals Circle
- MBS Program Should be Extended: Fed's Bullard
- Warren Buffett, Bill Gates 'Walk & Talk' At Columbia
- Microsoft, News Corp Weigh Online News Pact
- Senate Democrats at Odds Over Health Care Bill
RSS FEED
CNBC News Associate
Stocks continued to struggle on Friday. Could this be the beginning of a real market correction? Mike Rubino, president of Rubino Financial, and Paul Schatz, president of Heritage Capital, discussed how investors should position their portfolios for the end of the third quarter.
“I’ve been bullish for a while and over the next year, we’re going higher,” Schatz told CNBC.
“In the interim, the best chance for the first significant correction since the bull leg began in March is coming up early to mid-October."
"It lasts 4 to 6 weeks and we go down 7 to 17 percent. Other than that, we’ve been on an uptrend and it’s going to be a place to buy," Schatz said.
He believes the correction will be healthy for the markets and relatively small, compared to the 50 percent rally since March.
More Investor Intelligence:
In the meantime, Rubino is worried about consumers refusing to open their wallets to spend.
“Consumer spending has no chance of coming back with unemployment soaring and the housing market continuing to deleverage on a nationwide basis," he said. "I don’t see how consumers are comfortable spending when they’re worried about their assets being depleted.”
Schatz Likes:
S&P Consumer Staples
S&P Utilities
S&P Biotechnology
Rubino Likes:
Proshares Trust [TBT
Loading...
()
]
Proshares Short Oil & Gas [DDG
Loading...
()
]
Proshares Short Financials [SEF
Loading...
()
]
______________________________
Disclosure:
No immediate information was available for Rubino or Schatz.
______________________________
CNBC Slideshows:
______________________________
______________________________
Top Biotech Companies:
Amgen [AMGN
Loading...
()
]
Gilead Sciences [GILD
Loading...
()
]
Biogen [BIIB
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Amylin Pharmaceuticals [AMLN
Loading...
()
]
______________________________








